143 related articles for article (PubMed ID: 36244815)
41. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
Dawood NB; Tseng CH; Nguyen DT; Yan KL; Livhits MJ; Leung AM; Yeh MW
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4993-e5000. PubMed ID: 34313755
[TBL] [Abstract][Full Text] [Related]
42. Recent advances in the understanding and management of primary hyperparathyroidism.
Goldfarb M; Singer FR
F1000Res; 2020; 9():. PubMed ID: 32148764
[TBL] [Abstract][Full Text] [Related]
43. Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model.
Kebebew E; Hwang J; Reiff E; Duh QY; Clark OH
Arch Surg; 2006 Aug; 141(8):777-82; discussion 782. PubMed ID: 16924085
[TBL] [Abstract][Full Text] [Related]
44. Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.
Choi HR; Choi SH; Hong N; Rhee Y; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
J Korean Med Sci; 2022 Apr; 37(13):e99. PubMed ID: 35380024
[TBL] [Abstract][Full Text] [Related]
45. Surgical management of MILD hyperparathyroidism.
Lecourt A; Creff G; Coudert P; De Crouy Chanel O; Guggenbuhl P; Jegoux F
Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3901-3910. PubMed ID: 34328555
[TBL] [Abstract][Full Text] [Related]
46. Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.
Rajeev P; Movseysan A; Baharani A
Ann R Coll Surg Engl; 2017 Sep; 99(7):559-562. PubMed ID: 28853593
[TBL] [Abstract][Full Text] [Related]
47. Biochemical Profile Affects IOPTH Kinetics and Cure Rate in Primary Hyperparathyroidism.
Graves CE; McManus CM; Chabot JA; Lee JA; Kuo JH
World J Surg; 2020 Feb; 44(2):488-495. PubMed ID: 31511943
[TBL] [Abstract][Full Text] [Related]
48. Normocalcemic primary hyperparathyroidism.
Cusano NE; Cetani F
Arch Endocrinol Metab; 2022 Nov; 66(5):666-677. PubMed ID: 36382756
[TBL] [Abstract][Full Text] [Related]
49. Evaluation for Primary Hyperparathyroidism in Patients Who Present With Nephrolithiasis.
Behrens M; Boyle S; Fingeret AL
J Surg Res; 2021 Jan; 257():79-84. PubMed ID: 32818787
[TBL] [Abstract][Full Text] [Related]
50. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
Beyer TD; Solorzano CC; Prinz RA; Babu A; Nilubol N; Patel S
Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
[TBL] [Abstract][Full Text] [Related]
51. A practical approach to normocalcemic primary hyperparathyroidism.
Muñoz de Nova JL; Sampedro-Nuñez M; Huguet-Moreno I; Marazuela Azpiroz M
Endocrine; 2021 Nov; 74(2):235-244. PubMed ID: 34386939
[TBL] [Abstract][Full Text] [Related]
52. Mild primary hyperparathyroidism: a literature review.
Applewhite MK; Schneider DF
Oncologist; 2014 Sep; 19(9):919-29. PubMed ID: 25063228
[TBL] [Abstract][Full Text] [Related]
53. The Normohormonal Primary Hyperparathyroidism; a surgical dilemma pre and intra-operatively.
Fedorova T; Hagglund K; Hawasli A
Am J Surg; 2022 Mar; 223(3):589-591. PubMed ID: 35086696
[TBL] [Abstract][Full Text] [Related]
54. Intraoperative parathormone monitoring to predict operative success in patients with normohormonal hyperparathyroidism.
Stuart H; Azab B; Roque OP; Pasieka J; Lew JI
Can J Surg; 2022; 65(4):E468-E473. PubMed ID: 35902104
[TBL] [Abstract][Full Text] [Related]
55. Preoperative imaging predicts change in bone mineral density after parathyroidectomy for primary hyperparathyroidism.
Steinl GK; Yeh R; Walker MD; McManus C; Lee JA; Kuo JH
Bone; 2021 Apr; 145():115871. PubMed ID: 33540118
[TBL] [Abstract][Full Text] [Related]
56. Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.
Cipriani C; Abraham A; Silva BC; Cusano NE; Rubin MR; McMahon DJ; Zhang C; Hans D; Silverberg SJ; Bilezikian JP
Endocrine; 2017 Feb; 55(2):591-598. PubMed ID: 27757772
[TBL] [Abstract][Full Text] [Related]
57. What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy.
Chiu B; Sturgeon C; Angelos P
Surgery; 2006 Sep; 140(3):418-22. PubMed ID: 16934604
[TBL] [Abstract][Full Text] [Related]
58. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
[TBL] [Abstract][Full Text] [Related]
59. How should we define cure after parathyroidectomy for normocalcemic primary hyperparathyroidism? A retrospective cohort study.
Cano-Valderrama O; Ochagavía S; Sanabria C; Familiar C; Díaz J; Picazo S; Sáez-Carlin P; Torres AJ
Updates Surg; 2021 Dec; 73(6):2293-2299. PubMed ID: 34097295
[TBL] [Abstract][Full Text] [Related]
60. Re-operative Parathyroidectomy in Patients With Mild Primary Hyperparathyroidism.
Mainali B; Lindeman B; Chen H
J Surg Res; 2020 Nov; 255():130-134. PubMed ID: 32543378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
